Wearable Dark-adaptometer in Normal Adult Healthy Volunteers
NCT02674425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-07-01
Summary
Conventional dark-adaptometers are unsuitable as a mass screening tool due to their high cost, lack of easy portability, need of trained staff and a totally dark room to be operated, arbitrary testing procedures, associated time waste in clinic and patient burden to mention a few. Consequently, dark adaptometers are not routinely used as clinical tools for retinal diagnosis and monitoring despite the inherent benefits over other visual electrophysiology equipment such as the ERG system, whose cost and features may often be surplus to optometrists' requirements.
This trial will assess the dark-adaptometry testing performance of a novel light-emitting system by generating full dark-adaptation threshold functions in normal adult healthy volunteers.
The novel system has been proposed to overcome the issues associated with current instrumentation; it is semi-automatic and easy to use without the need of any skilled operator.
It is envisaged that this system could spread the practice of dark-adaptometry testing and its adoption by high-street optometrists. This will allow diagnosing a number of retinal pathologies more quickly and more reliably that, faced with an ageing population, represents a major asset to the Health Community and the NHS.
This trial will involve 20 healthy volunteers, distributed in equal number in 2 groups of 18-40 and 50-70 years old, respectively. Proven the good health and eye condition of the participants, one of their eyes will be randomly-allocated and undergo dark-adaptometry testing 3 times on separate days within 3 weeks.
Testing will clarify whether by using the novel system it is possible to reproduce state-of-the-art threshold measurements as good or better than those produced by commercially-available dark-adaptometers. Threshold measurements in the elderly will be compared with literature data adjusted to exclude aged crystalline lens and pupillary miosis contributions. Data variability and system usability will be also assessed.
Conditions
- Photoreceptor Sensitivity Thresholds
Interventions
- DEVICE
-
Dark Adaptometer
Sponsors & Collaborators
-
University of Liverpool
lead OTHER
Principal Investigators
-
Rachel L Williams, PhD · University of Liverpool
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2018-05-31
- Completion
- 2018-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision
NCT06076720 ·Status: UNKNOWN ·Phase: NA
-
Therapy of Age-related Macular Degeneration
NCT05222997 ·Status: UNKNOWN
-
Visual and Functional Assessment in Low Vision Patients
NCT01876147 ·Status: COMPLETED
-
Developing Better Computerised Vision Tests (CVTV)
NCT06224751 ·Status: RECRUITING
-
Dual Wavelength OCT
NCT03843840 ·Status: COMPLETED
-
Study of Dark Adaptation in Age-Related Macular Degeneration
NCT01352975 ·Status: ACTIVE_NOT_RECRUITING
-
Measuring Choroidal Thickness Using Optical Coherence Tomography
NCT06272851 ·Status: NOT_YET_RECRUITING
-
Mobile Electronic Devices for Visual Impairment
NCT03560765 ·Status: TERMINATED ·Phase: NA
-
The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
NCT07060196 ·Status: NOT_YET_RECRUITING
-
Development and Validation of an Automated Self-administered Visual Acuity System
NCT06540001 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Adaptive Optics Retinal Imaging
NCT02317328 ·Status: RECRUITING
-
Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT
NCT03686436 ·Status: UNKNOWN
-
Macular Function During Anti-VEGF Treatment
NCT01023971 ·Status: UNKNOWN
-
ARTIFICIAL INTELLIGENCE FOR MASS SCREENING OF THE DIABETIC RETINOPATHY IN THE CHERNIVTSI REGION (Pilot Study)
NCT06112691 ·Status: UNKNOWN
-
A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
NCT06557369 ·Status: RECRUITING ·Phase: NA
-
Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
NCT06879834 ·Status: RECRUITING
-
Optimising Visual Acuity Measurement in Macular Degeneration
NCT04920071 ·Status: COMPLETED
-
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
NCT01546181 ·Status: COMPLETED
-
OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration
NCT05569226 ·Status: UNKNOWN
-
Diabetic Retinopathy Screening in Private Practice
NCT02866734 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of the Observatory Battery of Common Eye Disorders for Adults With Intellectual Disability
NCT06737627 ·Status: RECRUITING
-
Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening
NCT02927561 ·Status: COMPLETED
-
Quality of Life Measures in Patients With Retinal Degeneration
NCT02814435 ·Status: COMPLETED
-
Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision
NCT06465212 ·Status: NOT_YET_RECRUITING
-
Direct Discrimination of Quantum States by the Human Eye
NCT05913063 ·Status: RECRUITING ·Phase: NA